Innovative Laser Technology Shows Promise in Facial Resurfacing: Study Reveals

An innovative 2910-nm erbium-doped glass fiber laser, recently sanctioned by the US Food and Drug Administration, has exhibited significant advancements in treating facial photoaging and rhytides. A recent study conducted at the Cleveland Clinic unveiled the laser’s efficacy, which led to high rates of patient satisfaction with reduced discomfort and downtime compared to traditional fractional lasers.

Dr. [Rita Swali], a dermatologist affiliated with the American Society for Laser Medicine and Surgery, expressed enthusiasm over the emerging evidence supporting the utilization of the 2910-nm laser for facial resurfacing. This specialized mid-infrared ablative fractional device operates at peak water absorption levels, promising minimal residual thermal damage and enhanced patient comfort.

The study, presented at the annual meeting of the American Society for Laser Medicine and Surgery, involved 15 participants undergoing three sessions with the 2910-nm laser. Patients, with a mean age of 65.7 years and varying Fitzpatrick skin types, reported an average discomfort level of 4.9 out of 10 and a satisfaction rating of 4.8 after the treatment regimen.

Utilizing the 5-point Global Aesthetic Improvement Scale, blind reviewers evaluated the digital images of the patients, resulting in an average score of 3.2 for overall appearance, 2.9 for wrinkles, 3.6 for pigment, 3.1 for skin texture, and 2.6 for skin laxity. Patients self-assessed with an average GAIS score of 3.8 for overall appearance.

The procedure’s side effects were transient, with edema and soft-tissue crusting lasting 3-5 days, and erythema typically resolving in 1-2 weeks. Notably, one instance of post-inflammatory hyperpigmentation (PIH) occurred but was successfully managed, allowing the patient to continue with the study.

Dr. [Rita Swali] commended the laser’s customizable settings and shorter downtime, emphasizing its potential to transform facial resurfacing procedures. With minimal discomfort and faster recovery times compared to traditional lasers, this technology offers a promising option for individuals seeking facial rejuvenation.

Disclosure: Dr. [Kristen Murray] disclosed financial ties to Acclaro Medical, the manufacturer of the 2910-nm laser, while Dr. [Rita Swali] reported no relevant relationships.